Research hub · 15 articles
Repair Peptides: BPC-157, TB-500, GHK-Cu
The repair-peptide cluster is the densest in this journal, and also the one where marketing language and published data diverge most sharply, which is why the articles here spend their space on mechanism and handling rather than on outcomes. BPC-157 is a fifteen-residue fragment derived from a gastric protein; TB-500 is the actin-binding domain of thymosin beta-4; GHK-Cu is a copper-binding tripeptide; KPV is the C-terminal tripeptide of alpha-MSH. Those origins explain the different research questions attached to each.
Three kinds of article sit in this hub. Mechanism pieces trace what each sequence is reported to do at the receptor or pathway level, with the caveat that most of the published work is preclinical. Reconstitution pieces carry the vial arithmetic for each compound, including the GHK-Cu case where copper coordination changes how the solution behaves. Comparison pieces do the work of putting two compounds side by side — BPC-157 against TB-500, KPV against BPC-157, GHK-Cu against BPC-157 — and the blends article covers what changes when two of them arrive in one vial at a fixed ratio. Read the mechanism pieces before the comparisons; the comparisons assume you already know what each component is.
A word on what is absent: this hub does not rank the four compounds against one another, because the published evidence does not support a ranking. What it does is make the differences in origin, sequence length and handling visible, so that a comparison between two of them is made on properties a laboratory can check rather than on category language.
Articles in this hub
BPC-157: The Complete Research Reference
Identity, stability, reconstitution arithmetic, the published animal models, and where the evidence stops — a single entry point to every BPC-157 page in the journal.
16 Nov 2026
BPC-157 Mechanism of Action: Repair Pathways
Angiogenesis, nitric-oxide modulation, fibroblast activity and GI mucosal protection — the mechanisms behind BPC-157's tissue-repair research profile.
13 Aug 2026
BPC-157 Dosage and Reconstitution Math: 5 mg Vial in the Lab
BPC-157 vial math — reconstituting a 5 mg lyophilized vial, mg to mL and U-100 unit conversions, and common research dose ranges.
13 Aug 2026
BPC-157 + TB-500 Blend: The Fixed 5 mg Ratio
The canonical repair-pathway blend explained — why 5:5 mg, how to reconstitute a 10 mg dual-vial, per-component dosing math, and when separate vials beat a blend.
10 Sept 2026
BPC-157 vs TB-500: Two Repair-Pathway Peptides Compared
Mechanism, molecular weight, reconstitution and research applications of BPC-157 (5 mg) and TB-500 (5 mg), the two most-asked-about repair peptides.
6 Aug 2026
BPC-157 and the 503A Bulks List: July 2026
BPC-157 was recommended for the FDA 503A Bulks List in July 2026 — what the vote means, what it doesn't change, and the research status of the pentadecapeptide.
15 Aug 2026
TB-500: The Thymosin Beta-4 Fragment, Explained
What TB-500 is, what the actin-binding domain does, and how the 5 mg vial reconstitutes — a practical research reference.
6 Aug 2026
TB-500 Mechanism: Thymosin Beta-4 Fragment
How TB-500's conserved actin-binding (LKKTETQ) domain drives the cell-migration and tissue-repair mechanisms studied in research.
14 Aug 2026
TB-500 Dosage and Reconstitution Math: 5 mg Vial in the Lab
TB-500 vial math — reconstituting a 5 mg thymosin beta-4 fragment vial, mg to mL and U-100 unit conversions, and common research dose ranges.
14 Aug 2026
GHK-Cu: The Copper Tripeptide, from Structure to Vial Math
What GHK-Cu is, what the copper atom changes, how the 50 mg vial reconstitutes, and why its molecular weight matters for molar work.
6 Aug 2026
GHK-Cu Reconstitution Math: 50 mg Vial
GHK-Cu (CU50) vial math — reconstituting a 50 mg copper tripeptide vial, mg to mL conversions, and the concentrations used in cell-culture work.
15 Aug 2026
GHK-Cu vs BPC-157: Copper Peptide vs Pentadecapeptide
Two tissue-focused peptides from different worlds — copper complex vs gastric pentadecapeptide, 50 mg vs 5 mg vial, and how each is studied.
6 Aug 2026
KPV Peptide: The Anti-Inflammatory α-MSH Fragment
KPV (Lys-Pro-Val), the C-terminal tripeptide of α-MSH, and its research profile in cytokine modulation, NF-κB signaling and mucosal integrity studies.
9 Aug 2026
KPV vs BPC-157: Tripeptide vs Pentadecapeptide
Comparing KPV (Lys-Pro-Val) and BPC-157 — two peptide research directions for inflammation and tissue repair, and how their mechanisms differ.
9 Aug 2026
GLOW & KLOW Blends: What's Inside the Four-Peptide Combos
GLOW (BPC-157 + GHK-Cu + TB-500) and KLOW (GLOW + KPV) — what each blend actually contains, why pre-blending at fixed ratios, and the reconstitution math per component.
8 Aug 2026
Related categories
Related tools
More hubs and compound references in the research journal; analytical documentation on the quality page; or request a quote.